Shares of Viridium Pacific Group Ltd (CVE:VIR) fell 13.6% on Thursday . The company traded as low as C$0.38 and last traded at C$0.38. 244,409 shares traded hands during mid-day trading, an increase of 147% from the average session volume of 98,972 shares. The stock had previously closed at C$0.44.

The stock has a market cap of $42.48 million and a price-to-earnings ratio of -2.97.

ILLEGAL ACTIVITY NOTICE: This article was published by Daily Political and is the property of of Daily Political. If you are reading this article on another website, it was illegally stolen and republished in violation of international copyright and trademark laws. The legal version of this article can be read at https://www.dailypolitical.com/2019/05/22/viridium-pacific-group-vir-shares-down-13-6.html.

Viridium Pacific Group Company Profile (CVE:VIR)

Viridium Pacific Group Ltd., through its subsidiaries, engages in the production, possession, and selling of medical cannabis in Canada. It is also involved in the contract manufacturing of cannabis oil capsules. The company provides its products for adult use, and wellness and therapeutic daily use.

Recommended Story: Determine Your Level of Risk Tolerance

Receive News & Ratings for Viridium Pacific Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viridium Pacific Group and related companies with MarketBeat.com's FREE daily email newsletter.